Compugen Announces USPTO Grants New Patent for Use of COM902
Express News | Compugen Expands Its Intellectual Property Portfolio With New U.S. Patent Covering Triple Combination Use of Com902 (Reduced Fc Anti-Tigit) With Anti-Pd-1 and Anti-Pvrig Antibodies
Roche Anti-TIGIT Therapy Fails to Extend Survival in Late-stage Lung Cancer Trial
Compugen Ltd. (NASDAQ:CGEN) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?
Truist Financial Maintains Compugen(CGEN.US) With Buy Rating
Compugen Reports Strong Q3 2024 Results and Progress
AddiBee0925 : Hey Jag. Just a heads up. If all goes as planned, the launch for SIDU and SpaceX is on the schedule for this Friday on the 20th. I wouldn't think that it would be rescheduled so soon to the launch, at least no report has said otherwise.
Jaguar8 OP AddiBee0925 : Yes. But there might be a build up of the price before the launch just like LUNR. Hopefully it goes well.
AddiBee0925 Jaguar8 OP : yeah I'm thinking the same
Jaguar8 OP browny_440 : TNXP will be good if FDA releases decision soon
72306783 : I would like to ask, what signals or standards do you use to start building positions? I am still learning... Thank you very much for your Share
View more comments...